286 related articles for article (PubMed ID: 32719615)
1. The Broad Spectrum of
Crasto S; My I; Di Pasquale E
Front Physiol; 2020; 11():761. PubMed ID: 32719615
[TBL] [Abstract][Full Text] [Related]
2. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
[TBL] [Abstract][Full Text] [Related]
3. From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy.
Veltrop RJA; Kukk MM; Topouzidou K; Didden L; Muchir A; van Steenbeek FG; Schurgers LJ; Harakalova M
Cell Commun Signal; 2024 Mar; 22(1):197. PubMed ID: 38539233
[TBL] [Abstract][Full Text] [Related]
4. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
5. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.
Taylor MR; Fain PR; Sinagra G; Robinson ML; Robertson AD; Carniel E; Di Lenarda A; Bohlmeyer TJ; Ferguson DA; Brodsky GL; Boucek MM; Lascor J; Moss AC; Li WL; Stetler GL; Muntoni F; Bristow MR; Mestroni L;
J Am Coll Cardiol; 2003 Mar; 41(5):771-80. PubMed ID: 12628721
[TBL] [Abstract][Full Text] [Related]
6. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
7. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
[TBL] [Abstract][Full Text] [Related]
8. Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies.
Wang X; Zabell A; Koh W; Tang WH
Curr Treat Options Cardiovasc Med; 2017 Mar; 19(3):21. PubMed ID: 28299614
[TBL] [Abstract][Full Text] [Related]
9. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.
Bonne G; Mercuri E; Muchir A; Urtizberea A; Bécane HM; Recan D; Merlini L; Wehnert M; Boor R; Reuner U; Vorgerd M; Wicklein EM; Eymard B; Duboc D; Penisson-Besnier I; Cuisset JM; Ferrer X; Desguerre I; Lacombe D; Bushby K; Pollitt C; Toniolo D; Fardeau M; Schwartz K; Muntoni F
Ann Neurol; 2000 Aug; 48(2):170-80. PubMed ID: 10939567
[TBL] [Abstract][Full Text] [Related]
11. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
Stallmeyer B; Koopmann M; Schulze-Bahr E
Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
[TBL] [Abstract][Full Text] [Related]
13. Heart involvement in lamin A/C related diseases.
Ben Yaou R; Gueneau L; Demay L; Stora S; Chikhaoui K; Richard P; Bonne G
Arch Mal Coeur Vaiss; 2006 Sep; 99(9):848-55. PubMed ID: 17067107
[TBL] [Abstract][Full Text] [Related]
14. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
[TBL] [Abstract][Full Text] [Related]
15. Non-syndromic cardiac progeria in a patient with the rare pathogenic p.Asp300Asn variant in the LMNA gene.
Marian AJ
BMC Med Genet; 2017 Oct; 18(1):116. PubMed ID: 29047356
[TBL] [Abstract][Full Text] [Related]
16. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation.
Hasselberg NE; Haland TF; Saberniak J; Brekke PH; Berge KE; Leren TP; Edvardsen T; Haugaa KH
Eur Heart J; 2018 Mar; 39(10):853-860. PubMed ID: 29095976
[TBL] [Abstract][Full Text] [Related]
17. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
[TBL] [Abstract][Full Text] [Related]
18. Complex phenotype linked to a mutation in exon 11 of the lamin A/C gene: Hypertrophic cardiomyopathy, atrioventricular block, severe dyslipidemia and diabetes.
Francisco ARG; Santos Gonçalves I; Veiga F; Mendes Pedro M; Pinto FJ; Brito D
Rev Port Cardiol; 2017 Sep; 36(9):669.e1-669.e4. PubMed ID: 28874324
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
[TBL] [Abstract][Full Text] [Related]
20. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
